{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T21:33:44Z","timestamp":1785188024319,"version":"3.55.0"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2017,7,13]],"date-time":"2017-07-13T00:00:00Z","timestamp":1499904000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000833","name":"Rosetrees Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000833","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000833","name":"Rosetrees Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000833","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["FS\/15\/29\/31492"],"award-info":[{"award-number":["FS\/15\/29\/31492"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0181077","type":"journal-article","created":{"date-parts":[[2017,7,13]],"date-time":"2017-07-13T17:49:46Z","timestamp":1499968186000},"page":"e0181077","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":15,"title":["Lipoprotein(a) in patients with aortic stenosis: Insights from cardiovascular magnetic resonance"],"prefix":"10.1371","volume":"12","author":[{"given":"Vassilios S.","family":"Vassiliou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul D.","family":"Flynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire E.","family":"Raphael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Newsome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aamir","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Halliday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annina","family":"Studer Bruengger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamir","family":"Malley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranev","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subothini","family":"Selvendran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Sri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Berry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackie","family":"Donovan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willis","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Auger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart A.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dudley J.","family":"Pennell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay K.","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,7,13]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1699-0463.1963.tb01808.x","article-title":"A new serum type system in man- the LP system","volume":"59","author":"K Berg","year":"1963","journal-title":"Acta Pathol Microbiol Scand"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1093\/eurheartj\/eht053","article-title":"When should we measure lipoprotein (a)?","volume":"34","author":"KM Kostner","year":"2013","journal-title":"Eur Heart J"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1093\/eurheartj\/ehq386","article-title":"Lipoprotein(a) as a cardiovascular risk factor: current status","volume":"31","author":"BG Nordestgaard","year":"2010","journal-title":"Eur Heart J"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/MOL.0b013e32835111d8","article-title":"Lipoprotein(a): more interesting than ever after 50 years","volume":"23","author":"JB Dub\u00e9","year":"2012","journal-title":"Curr Opin Lipidol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1093\/eurheartj\/ehr158","article-title":"ESC\/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)","volume":"32","author":"Z Reiner","year":"2011","journal-title":"Eur Heart J"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa1109034","article-title":"Genetic associations with valvular calcification and aortic stenosis","volume":"368","author":"G Thanassoulis","year":"2013","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jacc.2013.09.038","article-title":"Elevated lipoprotein(a) and risk of aortic valve stenosis in the general population","volume":"63","author":"PR Kamstrup","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.jacc.2015.07.020","article-title":"Oxidized Phospholipids, Lipoprotein(a), and Progression of Calcific Aortic Valve Stenosis","volume":"66","author":"R Capoulade","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"6671","DOI":"10.1021\/bi00241a006","article-title":"Tissue-type plasminogen activator binds to and is inhibited by surface-bound lipoprotein(a) and low-density lipoprotein","volume":"30","author":"DI Simon","year":"1991","journal-title":"Biochemistry"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.jacc.2015.07.045","article-title":"How Does Elevated Lipoprotein(a) Cause Aortic Valve Stenosis?","volume":"66","author":"BG Nordestgaard","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/330113a0","article-title":"Plasma lipoproteins: teaching old dogmas new tricks","volume":"330","author":"MS Brown","journal-title":"Nature"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1161\/CIRCULATIONAHA.115.016757","article-title":"Autotaxin Derived From Lipoprotein(a) and Valve Interstitial Cells Promotes Inflammation and Mineralization of the Aortic ValveCLINICAL PERSPECTIVE","volume":"132","author":"R Bouchareb","year":"2015","journal-title":"Circulation"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1161\/CIRCULATIONAHA.108.847772","article-title":"Impact of myocardial fibrosis in patients with symptomatic severe aortic stenosis","volume":"120","author":"F Weidemann","year":"2009","journal-title":"Circulation"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jacc.2009.12.074","article-title":"Prognostic significance of myocardial fibrosis quantification by histopathology and magnetic resonance imaging in patients with severe aortic valve disease","volume":"56","author":"CF Azevedo","year":"2010","journal-title":"J Am Coll Cardiol. Elsevier Inc"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1016\/j.jacc.2012.02.093","article-title":"Calcific aortic stenosis: a disease of the valve and the myocardium","volume":"60","author":"MR Dweck","year":"2012","journal-title":"J Am Coll Cardiol. Elsevier Inc"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1586\/14779072.2014.923307","article-title":"Markers of left ventricular decompensation in aortic stenosis","volume":"12","author":"CW Chin","year":"2014","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.jacc.2011.03.064","article-title":"Midwall fibrosis is an independent predictor of mortality in patients with aortic stenosis","volume":"58","author":"MR Dweck","year":"2011","journal-title":"J Am Coll Cardiol. Elsevier Inc"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jacc.2014.02.612","article-title":"Prognostic Significance of LGE by CMR in Aortic Stenosis Patients Undergoing Valve Replacement","volume":"64","author":"G Barone-Rochette","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1749-6632.2001.tb03514.x","article-title":"Inhibition of fibrinolysis by lipoprotein(a)","volume":"936","author":"E Angl\u00e9s-Cano","year":"2001","journal-title":"Ann N Y Acad Sci"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0009-3084(94)90159-7","article-title":"Effects of lipoprotein(a) on the binding of plasminogen to fibrin and its activation by fibrin-bound tissue-type plasminogen activator","volume":"67-68","author":"E Angl\u00e9s-Cano","year":"1994","journal-title":"Chem Phys Lipids"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/370460a0","article-title":"Activation of transforming growth factor-beta is inhibited in transgenic apolipoprotein(a) mice","volume":"370","author":"DJ Grainger","year":"1994","journal-title":"Nature"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1172\/JCI42028","article-title":"Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-\u03b2","volume":"120","author":"P Teekakirikul","year":"2010","journal-title":"J Clin Invest"},{"key":"ref23","first-page":"e1","article-title":"2014 AHA\/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"148","author":"R a Nishimura","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1001\/jama.2013.1363","article-title":"Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy","volume":"309","author":"A Gulati","year":"2013","journal-title":"JAMA"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2710.2011.01244.x","article-title":"Optimal therapy for reduction of lipoprotein(a)","volume":"37","author":"G Lippi","year":"2012","journal-title":"J Clin Pharm Ther"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/MOL.0000000000000131","article-title":"What is the ultimate test that lowering lipoprotein(a) is beneficial for cardiovascular disease and aortic stenosis?","volume":"25","author":"M-Y Hung","year":"2014","journal-title":"Curr Opin Lipidol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa0902604","article-title":"Genetic variants associated with Lp(a) lipoprotein level and coronary disease","volume":"361","author":"R Clarke","year":"2009","journal-title":"N Engl J Med"},{"key":"ref28","unstructured":"Kotar K, Thanassoulis G. Early Aortic Valve Lipoprotein(a) Lowering Trial (EAVaLL). In: ClinicalTrials.gov. 2015 p. NCT02109614."},{"key":"ref29","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1148\/radiol.14141120","article-title":"Assessment of diffuse myocardial fibrosis by using MR imaging in asymptomatic patients with aortic stenosis","volume":"274","author":"S-P Lee","year":"2015","journal-title":"Radiology"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12968-016-0275-9","article-title":"Magnetic resonance imaging phantoms for quality-control of myocardial T1 and ECV mapping: specific formulation, long-term stability and variation with heart rate and temperature","volume":"18","author":"VS Vassiliou","year":"2016","journal-title":"J Cardiovasc Magn Reson"},{"key":"ref31","article-title":"Identification of myocardial diffuse fibrosis by 11 heartbeat MOLLI T1 mapping: Averaging to improve precision and correlation with collagen volume fraction","author":"V Vassiliou","year":"2017","journal-title":"MAGMA"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.jacc.2017.01.034","article-title":"Midwall Fibrosis and 5-Year Outcome In Patients With Moderate and Severe Aortic Stenosis","volume":"69","author":"VS Vassiliou","year":"2017","journal-title":"J Am Coll Cardio"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.atherosclerosissup.2015.02.019","article-title":"The impact of lipoprotein apheresis in patients with refractory angina and raised lipoprotein(a): Objectives and methods of a randomised controlled trial","volume":"18","author":"TZ Khan","year":"2015","journal-title":"Atheroscler Suppl"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1093\/eurheartj\/ehx178","article-title":"Apheresis as novel treatment for refractory angina with raised lipoprotein(a): a randomized controlled cross-over trial","volume":"38","author":"TZ Khan","year":"2017","journal-title":"Eur Heart J"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"150315080057008","DOI":"10.1056\/NEJMoa1500858","article-title":"Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events","volume":"372","author":"MS Sabatine","year":"2015","journal-title":"N Engl J Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0181077","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T04:27:34Z","timestamp":1588998454000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0181077"}},"subtitle":[],"editor":[{"given":"Xianwu","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,7,13]]},"references-count":35,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2017,7,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0181077","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,13]]}}}